Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Clin Diagn Lab Immunol ; 4(2): 226-8, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9067661

ABSTRACT

The purpose of the present study was to measure serum concentrations of stem cell factor (SCF) and interleukin-3 (IL-3) in patients with acute Plasmodium falciparum malaria. Serum samples from 15 patients were taken on day of admission and days 7, 14, 21, and 28. Anemia developed in 80% of patients. A transient increase in IL-3 could be observed at the beginning of the disease. It remains controversial whether the measured concentrations of IL-3 and SCF correlate with the grade of anemia. The possibly suppressed IL-3 and SCF production may contribute to the prolonged anemia in P. falciparum malaria, as has been shown for erythropoietin.


Subject(s)
Anemia/etiology , Interleukin-3/blood , Malaria, Falciparum/blood , Malaria, Falciparum/complications , Stem Cell Factor/blood , Adolescent , Adult , Aged , Anemia/blood , Case-Control Studies , Erythropoiesis , Female , Hematocrit , Humans , Malaria, Falciparum/immunology , Male , Middle Aged
2.
Infection ; 24(3): 263-6, 1996.
Article in English | MEDLINE | ID: mdl-8811369

ABSTRACT

Candida sepsis during pregnancy is a rare but life-threatening complication of infection with Candida albicans. In contrast to the situation with other antimicrobial agents, there exists only limited experience with systemic antifungal therapy during pregnancy. A recent report focuses on amphotericin B treatment in systemic fungal infection during pregnancy. The present report discusses a pregnant patient with Candida albicans sepsis and endophthalmitis as well as candida infection of the oral and genital mucous membranes, after hyperalimentation and broad spectrum antibiotic therapy via a central venous catheter. The patient was treated with 10 mg/kg fluconazole from week 16 of gestation for a total duration of 50 days. Adverse effects did not occur and the rest of the pregnancy proceeded favourably for both the mother and the baby.


Subject(s)
Abortion, Septic/complications , Antifungal Agents/therapeutic use , Candida albicans/isolation & purification , Candidiasis/drug therapy , Endophthalmitis/complications , Fluconazole/therapeutic use , Sepsis/drug therapy , Adult , Candidiasis/complications , Candidiasis/microbiology , Female , Humans , Infant, Newborn , Pregnancy , Review Literature as Topic , Sepsis/complications , Sepsis/microbiology
3.
Am J Trop Med Hyg ; 54(3): 280-3, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8600766

ABSTRACT

The pathophysiologic backgrounds of anemia in malaria are complex and multifactorial. The purpose of the present study was to measure serum concentrations of erythropoietin (EPO) and to evaluate the adequacy of EPO production in patients suffering from acute Plasmodium falciparum malaria. Fifteen patients with complicated malaria were included in the study. Serum samples were taken on the day of admission, and days 7, 14, 21 and 28. Serum EPO concentrations were measured using an enzyme-linked immunosorbent assay. The median serum EPO concentration was 15.6 mU/ml on the day of admission (range 0.5-567) mU/ml, 10.6 mU/ml (1.2-863) on day 7, 11.8 mU/ml (0.5-72.8) on day 14, 10 mU/ml (0.5-74.6) on day 21, and 8.3 mU/ml (2.2-61.6) on day 28. Inadequate EPO production was found in 46.6% of the patients on the day of admission, which increased to 67% and 68% on days 7 and 14, and reached a maximum of 80% on day 21. Almost 54% of patients had inadequate EPO production on day 28. Our data indicate inadequate EPO production in patients suffering from acute P. falciparum malaria, which might contribute to the prolonged anemia observed in these patients.


Subject(s)
Erythropoietin/blood , Malaria, Falciparum/blood , Acute Disease , Adolescent , Adult , Anemia/blood , Anemia/etiology , Erythropoietin/biosynthesis , Hematocrit , Humans , Malaria, Falciparum/complications , Middle Aged
4.
Breast Cancer Res Treat ; 38(3): 283-8, 1996.
Article in English | MEDLINE | ID: mdl-8739081

ABSTRACT

Lymphedema of the arm is one of the most disabling and serious complications of breast cancer. Apart from tumor infiltration or fibrosis of lymphatic pathways, little is known about factors favoring the development of lymphedema. In the present study, we investigated the impact of rheologic parameters, e.g. red cell aggregation (EA) and plasma viscosity (PV), and of capillary morphology and capillary flow in patients with breast cancer with (n = 18) and without (n = 18) lymphedema. Patients with lymphedema showed a significant increase of red cell aggregation (p < 0.001) that indicates a systemic component of lymphedema and might offer a possibility of prevention and therapy of this condition. A hitherto unclassified protein factor favoring red cell aggregation and lymphedema might be postulated.


Subject(s)
Breast Neoplasms/blood supply , Hemorheology , Lymphedema/etiology , Mastectomy/adverse effects , Aged , Arm , Breast Neoplasms/surgery , Female , Humans , Middle Aged
6.
Dtsch Med Wochenschr ; 120(34-35): 1156-60, 1995 Aug 25.
Article in German | MEDLINE | ID: mdl-7656848

ABSTRACT

HISTORY AND CLINICAL FINDINGS: A 23-year-old woman suddenly had the sensation of a foreign body in her right eye. On looking into the mirror she saw what looked like a moving worm-like structure in the lateral angle of the eye. The patient had visited Cameroon 2 years previously. TESTS: On ophthalmological examination with a slit-lamp a transparent worm, 6-7 cm long, was seen. Laboratory tests showed an eosinophilia of 13%, C-reactive protein slightly raised to 1.25 mg/dl and IgG of 2100 mg/dl (IgE was normal at 33 U/ml). Giemsa staining of a whole-blood drop contained numerous microfilaria typical of Loa loa (2000/ml). Filaria serology with antigen of Dipetalonema vitae (Acanthocheilonema) gave a positive response. TREATMENT AND COURSE: The worm was removed surgically and, after a test dose, diethylcarbamazine, 6 mg/kg daily), was administered. Although methylprednisolone (initially 20 mg daily) was given concurrently, a fever of 38,5 degrees C developed on the 4th day. At the same time, streaky cutaneous eruptions were noted over the left lower arm and left knee bond. These two signs, which were due to two adult worms, disappeared within 2 days. On the 5th day the patient complained of headache, nausea and sensitivity to light, and she had meningism. The symptoms were treated with paracetamol and diazepam and quickly improved. The patient was discharged after 3 weeks. Further treatment cycles with diethylcarbamazine are planned.


Subject(s)
Eye Infections, Parasitic/diagnosis , Loiasis/diagnosis , Acetaminophen/therapeutic use , Adult , Animals , Cameroon , Diazepam/therapeutic use , Diethylcarbamazine/administration & dosage , Diethylcarbamazine/therapeutic use , Drug Administration Schedule , Eye Infections, Parasitic/surgery , Female , Humans , Loa/physiology , Loiasis/drug therapy , Meningism/etiology , Methylprednisolone/administration & dosage , Methylprednisolone/therapeutic use , Time Factors , Travel
7.
Eur J Clin Microbiol Infect Dis ; 14(7): 643-7, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7588858

ABSTRACT

Thirty-seven patients with acute exacerbations of chronic osteomyelitis caused by methicillin-susceptible Staphylococcus aureus (n = 13), methicillin-resistant Staphylococcus aureus (n = 12), methicillin-susceptible coagulase-negative staphylococci (n = 9), methicillin-resistant coagulase-negative staphylococci (n = 1) and enterococci (n = 2) were treated intravenously with teicoplanin. After a loading dose of 7 to 16 mg/kg (median 11 mg/kg) for 4 to 7 days, patients received 9 to 25 mg/kg (median 14 mg/kg) on Mondays, Wednesdays and Fridays in an outpatient setting to reach trough serum levels between 5 mg/l and 15 mg/l. The duration of treatment ranged from 28 to 150 days (median 60 days). Cure was obtained in 14 (38%) and improvement in 17 (46%) cases, and failure was observed in 6 (16%) patients. Adverse effects occurred in 6 patients, and caused discontinuation of treatment in 3 patients. The financial savings exceeded US$60,000 per patient compared with the high hospitalization costs of inpatient treatment.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Osteomyelitis/drug therapy , Teicoplanin/therapeutic use , Adolescent , Adult , Aged , Ambulatory Care Facilities , Child , Chronic Disease , Female , Humans , Injections, Intravenous , Male , Middle Aged , Staphylococcal Infections/drug therapy , Teicoplanin/administration & dosage
8.
Antimicrob Agents Chemother ; 39(3): 672-6, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7793871

ABSTRACT

Thirty patients with severe bacterial infections were treated with 50 mg of cefodizime per kg of body weight once daily or 50 mg of ceftriaxone per kg once daily for 10 +/- 3 days. The effect of cefodizime and ceftriaxone on the phagocytic capacity and generation of reactive oxygen intermediates after phagocytosis by granulocytes was assessed prior to, during, and after therapy. Flow cytometry was used to study phagocytic capacity by measuring the uptake of fluorescein-labeled bacteria. The generation of reactive oxygen intermediates after phagocytosis was estimated by the quantification of the intracellular conversion of dihydrorhodamine 123 to rhodamine 123. Prior to therapy, patients in both groups exhibited a decreased capacity to phagocytize Escherichia coli and subsequently to generate reactive oxygen intermediates. Granulocyte function increased after the initiation of therapy and normalized within 7 days for the ceftriaxone-treated patients and within 3 days for the cefodizime group (P < 0.05). In the cefodizime group, an enhancement of phagocytic capacity was observed 14 days after the initiation of therapy (P < 0.05). Prior to therapy, phagocytic capacity was significantly correlated with the generation of reactive oxygen products (r = 0.674 and P < 0.005).


Subject(s)
Bacterial Infections/blood , Cefotaxime/analogs & derivatives , Ceftriaxone/adverse effects , Phagocytes/drug effects , Adolescent , Adult , Aged , Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Cefotaxime/adverse effects , Cefotaxime/therapeutic use , Ceftriaxone/therapeutic use , Escherichia coli , Female , Flow Cytometry , Granulocytes/drug effects , Granulocytes/metabolism , Humans , In Vitro Techniques , Male , Middle Aged , Neutrophils/drug effects , Phagocytes/metabolism , Phagocytes/microbiology , Phagocytosis/drug effects , Reactive Oxygen Species/metabolism
10.
Infection ; 22(6): 420-2, 1994.
Article in English | MEDLINE | ID: mdl-7698841

ABSTRACT

Extrapulmonary tuberculosis has a broad spectrum of clinical manifestations. Involvement of the thyroid gland has rarely been reported. We report a case in a patient with a non-tender swelling of the thyroid, whose symptoms, sonographic and scintigraphic features mimicked carcinoma. Initially the patient presented with back pain due to a paravertebral mass. Fine needle aspiration and culture of the aspirate both from the paravertebral mass and the thyroid ensured the diagnosis. Although seldom observed, tuberculosis should be kept in mind in the differential diagnosis of nodular lesions of the thyroid. The preponderant absence of thyroid dysfunction in mycobacterial thyroiditis is confirmed by this case.


Subject(s)
Abscess/diagnosis , Thyroid Diseases/diagnosis , Tuberculosis, Endocrine/diagnosis , Tuberculosis, Spinal/diagnosis , Abscess/complications , Adult , Diagnosis, Differential , Humans , Male , Thyroid Diseases/complications , Thyroiditis/microbiology , Tuberculosis, Endocrine/complications , Tuberculosis, Spinal/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...